Prostatic Diseases

Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617

Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection

Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging

Test Semiquantitative Prostate Specific Antigen (PSA)

Health Gatherings - For Your Health After Cancer

Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer

18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

European Registry for Transperineal Laser Ablation of Prostate (TPLA) for Lower Urinary Tract Symptoms

Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics

MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia

Low-energy Extracorporeal Shockwave Treatment for Patients After Radical Prostatectomy

Prostatic Artery Embolization for Benign Prostatic Obstruction

Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer

A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancer

Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer

Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy

Character Traits and Stress in Suspected Prostate Cancer

Transluminal Flexible Endoscopic Procedure in Foregut and Urologic Surgery